Sanofi Nabs Priority Review For New Pompe Drug

And Rilzabritib Gets US Fast Track For ITP

 
• By Kevin Grogan
  
sanofi fast track
Avalglucosidase alfa and rilzabrutinib on track • Source: Shutterstock

More from Rare Diseases

More from Scrip